Both in Pharmaceuticals
Briacell Therapeutics vs Celularity
Over the past year BCTX returned −69.9% and CELU returned −52.5%; their daily moves had a correlation of 0.03.
BCTX −69.9% CELU −52.5%Growth of $1, one year, split-adjusted
| Metric | BCTX | CELU |
|---|---|---|
| Price | $3.01 | $0.8171 |
| Market cap | $26.3M | $26.5M |
| Today | −2.59% | +1.82% |
| 1 month | −28.0% | −52.2% |
| 6 months | −26.0% | −14.3% |
| Year to date | −57.7% | −26.4% |
| 1 year | −72.6% | −58.1% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $20.5M | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | 76.1% | 223.1% |
| Short % of float | 9.3% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).